- The global bile duct cancer market refers to the industry focused on the diagnosis, treatment, research, and development of therapies and technologies associated with bile duct cancer, also known as cholangiocarcinoma
- This cancer originates in the bile ducts, which are thin tubes responsible for carrying bile — a digestive fluid — from the liver and gallbladder to the small intestine
- North America is expected to dominate the bile duct cancers market with 40.2% due to well-established healthcare system, advanced diagnostic technologies, and a high adoption rate of innovative therapies
- Asia-Pacific is expected to be the fastest growing region in the bile duct cancer market during the forecast period due to Rapid economic development and improvements in healthcare infrastructure
- Chemotherapy segment is expected to dominate the market with a market share of 50.1% due to its proven efficacy as well as widespread acceptance among medical practitioners
